Match tier Likely match
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-06

Jawad Muayad

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

M.D.

Also affiliated: Ain Shams University (2026); University of Jordan (2024–2026); Texas A&M Health Science Center (2026); Houston Methodist (2023–2026); Hashemite University (2026); University of Illinois Urbana-Champaign (2026); Baylor College of Medicine (2023–2024); Cornell University (2023); University of Arkansas Medical Center (2026); University of Iowa Hospitals and Clinics (2026); Ain Shams University Hospital (2026); Associated Retinal Consultants (2026); Weill Cornell Medicine (2023–2026); The University of Texas Medical Branch at Galveston (2023); Texas A&M University (2024–2026)

4 h-index 47 pubs 91 cited

  • Female
  • Humans
  • Male
  • Retrospective Studies
  • Middle Aged
  • Risk Factors
  • Aged
  • Incidence
  • Diabetes Mellitus, Type 2
  • Follow-Up Studies
  • Adult
  • Diabetic Retinopathy
  • Aged, 80 and over
  • Cataract Extraction
  • Propensity Score

Biography and Research Information

OverviewAI-generated summary

Jawad Muayad's research focuses on the epidemiological aspects and risk factors associated with various ocular and systemic conditions, particularly in patients with type 2 diabetes. His work has investigated the comparative effects of different pharmacological interventions, such as glucagon-like peptide 1 receptor agonists and metformin, on glaucoma risk. Muayad has also examined the influence of common medications on diabetic macular edema and the role of statin intensity in modulating the risk of age-related macular degeneration. His research extends to the epidemiology of sarcoid uveitis and the risk of uveitis among e-cigarette users. Additionally, he studies the progression of diabetic retinopathy and assesses the risk of kidney stone development in patients treated with carbonic anhydrase inhibitors.

Metrics

  • h-index: 4
  • Publications: 47
  • Citations: 91

Positions

  • Texas A&M University publications 2024–2026
    ORCID
  • M.D. publications 2026
    University of Arkansas for Medical Sciences Institution web page

Selected Publications

  • Large-scale analysis of risk factors for developing retinal vein occlusion in the fellow eye (2026)
  • Risk and Predictors of Fellow-Eye Involvement after Unilateral Retinal Artery Occlusion (2026)
    Ophthalmology Retina DOI OpenAlex
  • Comparative Five-Year Risks of Systemic Complications with Biologic versus Conventional Therapy in Noninfectious Uveitis (2026)
    Ophthalmology DOI OpenAlex
  • Statin Intensity and the Risk of Noninfectious Uveitis (2026)
    Ophthalmology Retina DOI OpenAlex
  • Systemic Anemia and the Risk of Diabetic Macular Edema and Anti-VEGF Injections (2026)
    Ophthalmology Retina 1 citation DOI OpenAlex
  • The Association Between Uveitis and Optic Neuritis in Central Nervous System Demyelinating Disorders: A Multi-Institutional Cohort Study (2026)
    Journal of Neuro-Ophthalmology DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

25 Collaborators 14 Institutions 3 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics